Cargando…
Comprehensive tumor molecular profile analysis in clinical practice
BACKGROUND: Tumor molecular profile analysis by Next Generation Sequencing technology is currently widely applied in clinical practice and has enabled the detection of predictive biomarkers of response to targeted treatment. In parallel with targeted therapies, immunotherapies are also evolving, rev...
Autores principales: | Özdoğan, Mustafa, Papadopoulou, Eirini, Tsoulos, Nikolaos, Tsantikidi, Aikaterini, Mariatou, Vasiliki-Metaxa, Tsaousis, Georgios, Kapeni, Evgenia, Bourkoula, Evgenia, Fotiou, Dimitrios, Kapetsis, Georgios, Boukovinas, Ioannis, Touroutoglou, Nikolaos, Fassas, Athanasios, Adamidis, Achilleas, Kosmidis, Paraskevas, Trafalis, Dimitrios, Galani, Eleni, Lypas, George, Orhan, Bülent, Tansan, Sualp, Özatlı, Tahsin, Kırca, Onder, Çakır, Okan, Nasioulas, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045191/ https://www.ncbi.nlm.nih.gov/pubmed/33853586 http://dx.doi.org/10.1186/s12920-021-00952-9 |
Ejemplares similares
-
Molecular predictive markers in tumors of the gastrointestinal tract
por: Papadopoulou, Eirini, et al.
Publicado: (2016) -
Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients
por: Papadopoulou, Eirini, et al.
Publicado: (2019) -
The Utility of NGS Analysis in Homologous Recombination Deficiency Tracking
por: Tsantikidi, Aikaterini, et al.
Publicado: (2023) -
Tumor molecular profiling of NSCLC patients using next generation sequencing
por: Tsoulos, Nikolaos, et al.
Publicado: (2017) -
Report of a germline double heterozygote in MSH2 and PALB2
por: Agiannitopoulos, Konstantinos, et al.
Publicado: (2020)